Neurotech International (ASX:NTI) has reported positive preclinical research demonstrating that its NTI164 can improve diclofenac efficacy at low doses.
Neurotech International
ASX:NTI
Footer
Suite 5 CPC, 145 Stirling Highway
Nedlands WA 6009
Australia
+61 (8) 9389 3130